Brief: Mateon Provides Update On Its Rapid Antiviral Response Program Initially Targeting Covid-19

Oncotelic Therapeutics

02/03/2020 12:51

March 2 (Reuters) - Mateon Therapeutics Inc  MATN.PK :
    * MATEON PROVIDES UPDATE ON ITS RAPID ANTIVIRAL RESPONSE
PROGRAM
INITIALLY TARGETING COVID-19
    * MATEON THERAPEUTICS - BEEN EVALUATING THERAPEUTIC AND AI
PLATFORMS TO AID IN TREATMENT OF CURRENT COVID-19 VIRUS OUTBREAK
    * MATEON THERAPEUTICS INC - HAS MADE SIGNIFICANT PROGRESS IN
DEPLOYING ITS CLINICAL ASSETS AGAINST COVID-19 VIRUS
    * MATEON THERAPEUTICS INC - NEW DIVISION HAS ALREADY
IDENTIFIED
INITIAL ANTI-VIRAL CANDIDATES AND HAS ENTERED INTO
COLLABORATIONS WITH RESEARCHERS

Source text for Eikon:  ID:nGNX4jhSWF 
Further company coverage:  MATN.PK 

 ((Reuters.Briefs@thomsonreuters.com;))